Fonte: European Journal of Clinical Pharmacology. Unidade: FCF
Assuntos: FARMACOLOGIA, FARMACOCINÉTICA, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELLA PASCHOA, O E et al. Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem. European Journal of Clinical Pharmacology, v. 48, n. 1 , p. 45-9, 1995Tradução . . Disponível em: https://doi.org/10.1007/bf00202171. Acesso em: 07 out. 2024.APA
Della Paschoa, O. E., Luckow, V., Trenk, D., Jahnchen, E., & Santos, S. R. C. J. (1995). Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem. European Journal of Clinical Pharmacology, 48( 1 ), 45-9. doi:10.1007/bf00202171NLM
Della Paschoa OE, Luckow V, Trenk D, Jahnchen E, Santos SRCJ. Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem [Internet]. European Journal of Clinical Pharmacology. 1995 ;48( 1 ): 45-9.[citado 2024 out. 07 ] Available from: https://doi.org/10.1007/bf00202171Vancouver
Della Paschoa OE, Luckow V, Trenk D, Jahnchen E, Santos SRCJ. Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem [Internet]. European Journal of Clinical Pharmacology. 1995 ;48( 1 ): 45-9.[citado 2024 out. 07 ] Available from: https://doi.org/10.1007/bf00202171
